<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url><loc>https://www.fershman.com/articles/ai-margin-compression-will-test-cccs-moat</loc><news:news><news:publication><news:name>The Fershman Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T16:00:00+00:00</news:publication_date><news:title>AI Will Test CCC’s Moat</news:title></news:news></url>
<url><loc>https://www.fershman.com/articles/to-delay-or-not-to-delay-was-oura-right-to-postpone-its-ipo</loc><news:news><news:publication><news:name>The Fershman Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T15:00:00+00:00</news:publication_date><news:title>To Delay or Not to Delay: Was Oura Right to Postpone Its IPO?</news:title></news:news></url>
<url><loc>https://www.fershman.com/articles/quanta-services-a-great-business-but-what-is-it-truly-worth</loc><news:news><news:publication><news:name>The Fershman Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T14:21:22.067+00:00</news:publication_date><news:title>Quanta Services: A Great Business, but What Is It Truly Worth?</news:title></news:news></url>
<url><loc>https://www.fershman.com/articles/stellantis-leapmotor-partnership-to-deepen-ev-production-in-europe</loc><news:news><news:publication><news:name>The Fershman Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T14:20:55.867+00:00</news:publication_date><news:title>Stellantis × Leapmotor Partnership to deepen EV Production in Europe</news:title></news:news></url>
<url><loc>https://www.fershman.com/articles/openai-acquiring-biotech-startup</loc><news:news><news:publication><news:name>The Fershman Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T10:48:00+00:00</news:publication_date><news:title>OpenAI’s Bet on Faster Drug Development</news:title></news:news></url>
<url><loc>https://www.fershman.com/articles/grindrs-250-million-acquisition-of-purposemed-expanding-into-healthcare</loc><news:news><news:publication><news:name>The Fershman Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T10:42:00+00:00</news:publication_date><news:title>Grindr’s $250M Bet on Healthcare</news:title></news:news></url>
<url><loc>https://www.fershman.com/articles/a-drug-that-decides-where-to-work</loc><news:news><news:publication><news:name>The Fershman Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T10:39:00+00:00</news:publication_date><news:title>The Drug That Decides Where to Work</news:title></news:news></url>
</urlset>